Skip Navigation
Markets
Business
Investing
Tech
Politics
CNBC TV
Watchlist
PRO

Moderna Inc MRNA:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/05/21 EST
132.19quote price arrow down-0.11 (-0.08%)
Volume
11,850,416
52 week range
19.31 - 189.26

...

Loading . . .

KEY STATS

  • Open133.07
  • Day High134.27
  • Day Low121.12
  • Prev Close132.19
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low19.31
  • 52 Week Low Date03/13/20
  • Market Cap52.846B
  • Shares Out399.77M
  • 10 Day Average Volume12.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.5
  • 1 Year % Change346.44

RATIOS/PROFITABILITY

  • EPS (TTM)-1.94
  • P/E (TTM)-68.24
  • Fwd P/E (NTM)8.82
  • EBITDA (MRQ)-731.893M
  • ROE (MRQ)-39.99%
  • Revenue (MRQ)803.40M
  • Gross Margin (MRQ)70.05%
  • Net Margin (MRQ)-92.99%
  • Debt To Equity (MRQ)4.29%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Moderna Inc News

Latest MRNA News From Our Partners

QUOTE FINDER

Related Video

VIDEO2:2502:25
Johnson & Johnson's Covid vaccine rolls out across the U.S., boosting supplies

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States
https://www.modernatx.com/